Revolution Medicines, Inc 10-Q for FY2022 Q2
Revolution Medicines, Inc. (RVMD)
10-Q
2022-08-09
For: 2022-06-30
View Original
Added on
April 10, 2026
About this 10-Q
Revolution Medicines, Inc filed this 10-Q on August 9, 2022, covering the quarter ended June 30, 2022 (FY2022 Q2).
Headline figures
Quarter ended June 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $9.12M
- up 4.8% from $8.7M a year earlier
- Net loss
- $61.22M
- compared with a net loss of $44.3M a year earlier
- Diluted EPS
- -$0.82
- compared with -$0.60 a year earlier